Search

Your search keyword '"Matthew D Wilkerson"' showing total 284 results

Search Constraints

Start Over You searched for: Author "Matthew D Wilkerson" Remove constraint Author: "Matthew D Wilkerson"
284 results on '"Matthew D Wilkerson"'

Search Results

151. Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

152. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

153. Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity

154. Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens

155. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

156. 'Soldier's Heart': A Genetic Basis for Elevated Cardiovascular Disease Risk Associated with Post-traumatic Stress Disorder

157. Integrated Molecular Characterization of Uterine Carcinosarcoma

158. Cafeteria diet-induced obesity causes oxidative damage in white adipose

159. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

160. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

161. Abstract 5352: Racial/ethnic differences in prostate cancer genomic alterations

162. Abstract 5354: Novel genomic alterations in renal medullary carcinoma tumors

163. Abstract 2281: Flexible discovery of recurrent coding and non-coding mutations in tumor whole genomes

164. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer

165. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

166. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

167. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

168. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma

169. DNA defects, epigenetics, and gene expression in cancer-adjacent breast: A study from the cancer genome atlas

170. Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

171. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

172. The molecular taxonomy of primary prostate cancer

173. Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke

174. Genomic Classification of Cutaneous Melanoma

175. Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC

176. a genomic-based classification of lung tumors

177. The Integrated Genomic Landscape of Thymic Epithelial Tumors

178. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

179. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

180. Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

181. Comprehensive genomic profiles of small cell lung cancer

182. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

183. Abstract 5403: Reproducible elevation of RNA versus DNA mutation signal in low purity breast tumors

184. Abstract 4254: Improved understanding of the etiology of breast cancer in young women through evaluation of the genomic landscape

185. Abstract 3259: The genomic landscape of premalignant lung squamous cell carcinoma lesions

186. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

187. Characterization of HPV and host genome interactions in primary head and neck cancers

188. The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

189. Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

190. ABRA: improved coding indel detection via assembly-based realignment

191. The Cancer Genome Atlas Pan-Cancer analysis project

192. Comprehensive molecular characterization of urothelial bladder carcinoma

193. Comprehensive molecular profiling of lung adenocarcinoma

194. Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

195. Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets

196. A Genomics-Based Classification of Human Lung Tumors

197. Cytokine regulation central to ulipristal-mediated leiomyoma treatment

198. Abstract 4371: Integrated molecular characterization of pheochromocytoma and paraganglioma including a novel, recurrent and prognostic fusion gene

199. EGFR mutation signature in lung adenocarcinoma

200. 401 Dermal fibroblasts with loss of TSC2 express increased galectin-3, a potential biomarker for tuberous sclerosis complex

Catalog

Books, media, physical & digital resources